Clinical outcome of emergency egg vitrification for women when sperm extraction from the testicular tissues of the male partner is not successful

Figures & data

Table 1. Patient demographic characteristics.

No. of patient	Age (yrs)	Duration of Infertility (yrs)	Day 3 FSH level (IU/L)	Day 3 LH level (IU/L)	Day 3 Estradiol level (pg/L)
1	24	2	5.2	4.5	24.4
2	29	2	5.2	4.7	66.7
3	34	11	8.2	5.6	27.0
4	29	5	7.6	5.8	30.5
5	28	5	4.0	3.7	35.7
6	30	5	7.5	3.1	60.0
7	23	1	4.1	9.5	106.6
8	28	5	5.3	4.8	42.4
9	28	3	6.7	3.5	20.2
10	27	4	6.0	5.2	31.0
11	30	4	6.8	11.7	37.6
12	24	3	6.4	5.3	37.8
13	27	4	5.3	4.9	50.2
14	29	5	7.0	5.6	45.5
15	29	3	4.2	15.6	61.2
Mean ± SD	28.2± 2.9	4.3 ± 2.6	6.1 ± 1.4	5.6 ± 2.6	43.8 ± 25.3

FSH: follicle-stimulating hormone; LH: luteinizing hormone.

Table 2. Clinical outcomes following transfer of embryos produced from vitrified oocytes.

Group characteristics	Value
Patients who underwent thawing and embryo transfer	15
Mature (M-II) oocytes retrieved	117
M-II oocytes vitrified and thawed	117
Oocytes survived (%)	99 (84.6)
Oocytes fertilized (%)	83 (83.8)
Oocytes cleaved (%)	75 (90.4)
Embryos transferred (mean±SD)	30 (2.0±0.8)
Clinical pregnancy rate per cycle started (%)	8 (53.3)
Embryos implanted (%)	9 (30.0)
Singleton pregnancies	7
Twin pregnancies	1
Live-birth rate per cycle thawed (%)	8 (53.3)
Newborns	9

Table 3. Obstetric and perinatal outcomes of each patient following oocyte vitrification and thawing.

Patient number	Singleton (S) or twin (T)	Gestational age (week+days)	Birth weight (g)	Karyotype	Birth defect (yes or no)
2	S	40	4,000	XY	no
3	S	39+2	4,400	XY	no
4	S	40	3,250	XY	no
6	S	39+3	3,500	XX	no
7	S	40	3,850	XY	no
10	S	40	4,100	XX	no
12	S	39+6	3,550	XY	no
Mean±SD		39+5	3,807±397.3
14	T	35	3,000; 2,250	XX; XX	no
Mean±SD		38 +6	2,625±530.3